Prognostic role of CA-125 nadir in stage IV epithelial ovarian cancer

J Clin Oncol. 2008 Apr 1;26(10):1771-2; author reply 1772. doi: 10.1200/JCO.2007.15.7594.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Biomarkers, Tumor / blood*
  • CA-125 Antigen / blood*
  • Female
  • Humans
  • Ovarian Neoplasms / blood*
  • Ovarian Neoplasms / metabolism
  • Ovarian Neoplasms / pathology*
  • Prognosis

Substances

  • Biomarkers, Tumor
  • CA-125 Antigen